Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Watanabe

Showing results (631-640 of 876) with videos related to

Pageof 88
Sort By:
The Journal of Dermatology|February 29, 2024
Clinical features of patients with connective tissue disease with anti-human upstream binding factor antibodies: A single-center retrospective studyNatsumi Fushida, Motoki Horii, Ko Fujii, et al.
Plos One|December 6, 2019
Characterization and quantitative trait locus mapping of late-flowering from a Thai soybean cultivar introduced into a photoperiod-insensitive genetic backgroundFei Sun, Meilan Xu, Cheolwoo Park, et al.
International Archives of Allergy and Immunology|May 26, 2023
Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic AsthmaNatsumi Sakai, Toshiyuki Koya, Yui Murai, et al.
JACC. Case Reports|July 28, 2021
Calcified Nodules in the Superficial Femoral Artery Confirmed by Intravascular Ultrasound, Angioscopy, and HistologyKota Tanaka, Hiroyuki Nagai, Atsunori Okamura, et al.
BMC Cancer|March 2, 2021
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027Yuji Minegishi, Ou Yamaguchi, Shunichi Sugawara, et al.
Rheumatology (Oxford, England)|December 1, 2021
Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathyYuri Okada, Rumiko Izumi, Tatsuhiko Hosaka, et al.
Anticancer Research|August 1, 2018
Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIsSatoshi Watanabe, O U Yamaguchi, A I Masumoto, et al.
International Journal of Cardiology|May 13, 2014
Maximum phonation time is related to disease severity in male chronic heart failure patientsKazuhiro P Izawa, Satoshi Watanabe, Shinobu Tochimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861QSatoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa, et al.
Journal of Thoracic Disease|April 15, 2024
Patients with idiopathic pulmonary fibrosis and refractory cough have traction bronchiectasis and distorted airway architecture: a retrospective case review studyKenta Yamamura, Johsuke Hara, Satoshi Watanabe, et al.
Pageof 88

Showing results (631-640 of 876) with videos related to

Sort By:
Pageof 88
The Journal of Dermatology|February 29, 2024
Clinical features of patients with connective tissue disease with anti-human upstream binding factor antibodies: A single-center retrospective studyNatsumi Fushida, Motoki Horii, Ko Fujii, et al.
Plos One|December 6, 2019
Characterization and quantitative trait locus mapping of late-flowering from a Thai soybean cultivar introduced into a photoperiod-insensitive genetic backgroundFei Sun, Meilan Xu, Cheolwoo Park, et al.
International Archives of Allergy and Immunology|May 26, 2023
Effect of Benralizumab on Mucus Plugs in Severe Eosinophilic AsthmaNatsumi Sakai, Toshiyuki Koya, Yui Murai, et al.
JACC. Case Reports|July 28, 2021
Calcified Nodules in the Superficial Femoral Artery Confirmed by Intravascular Ultrasound, Angioscopy, and HistologyKota Tanaka, Hiroyuki Nagai, Atsunori Okamura, et al.
BMC Cancer|March 2, 2021
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027Yuji Minegishi, Ou Yamaguchi, Shunichi Sugawara, et al.
Rheumatology (Oxford, England)|December 1, 2021
Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathyYuri Okada, Rumiko Izumi, Tatsuhiko Hosaka, et al.
Anticancer Research|August 1, 2018
Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIsSatoshi Watanabe, O U Yamaguchi, A I Masumoto, et al.
International Journal of Cardiology|May 13, 2014
Maximum phonation time is related to disease severity in male chronic heart failure patientsKazuhiro P Izawa, Satoshi Watanabe, Shinobu Tochimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861QSatoshi Watanabe, Yuji Minegishi, Hirohisa Yoshizawa, et al.
Journal of Thoracic Disease|April 15, 2024
Patients with idiopathic pulmonary fibrosis and refractory cough have traction bronchiectasis and distorted airway architecture: a retrospective case review studyKenta Yamamura, Johsuke Hara, Satoshi Watanabe, et al.
Pageof 88